C5AR2 and lung cancer: In this regard, targeting CD10 and G protein-coupled receptor 77 (GPR77), two markers for a specific CAF subset that correlates with chemoresistance and poor survival in multiple cohorts of breast and lung cancer patients, could be an effective therapeutic strategy, as suggested [63].